SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,654,770 | +10.2% | 7,800 | 0.0% | 0.55% | +26.8% |
| Q2 2023 | $1,501,188 | -4.9% | 7,800 | 0.0% | 0.43% | -6.9% |
| Q1 2023 | $1,579,266 | +57.6% | 7,800 | 0.0% | 0.46% | +53.0% |
| Q4 2022 | $1,002,378 | -6.1% | 7,800 | 0.0% | 0.30% | -16.0% |
| Q3 2022 | $1,067,000 | -22.7% | 7,800 | 0.0% | 0.36% | -19.0% |
| Q2 2022 | $1,380,000 | +22.8% | 7,800 | 0.0% | 0.45% | +45.6% |
| Q1 2022 | $1,124,000 | -6.8% | 7,800 | 0.0% | 0.31% | -1.9% |
| Q4 2021 | $1,206,000 | -8.9% | 7,800 | 0.0% | 0.31% | -17.4% |
| Q3 2021 | $1,324,000 | +7.6% | 7,800 | 0.0% | 0.38% | +8.3% |
| Q2 2021 | $1,231,000 | +13.7% | 7,800 | 0.0% | 0.35% | +12.9% |
| Q1 2021 | $1,083,000 | -20.7% | 7,800 | 0.0% | 0.31% | -25.5% |
| Q4 2020 | $1,366,000 | – | 7,800 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |